XM does not provide services to residents of the United States of America.
U
U

Ubisoft

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

British Business - Oct 9

PRESS DIGEST-British Business - Oct 9 Oct 9 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Ubisoft UBIP.PA , the beleaguered video games studio behind the "Assassin's Creed" franchise, has said it is reviewing strategic options following fresh reports that it could be taken private.
G
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Nissan, Duckhorn, Blue Owl, Heidelberg, Arcadium Updates: Chevron, Barnes Group Oct 7 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 14 17 GMT on Monday: * * Japan's Nissan Motor 7201.T said on Monday it would invest an undisclosed amount in ChargeScape and roll out the battery charging technology company's services to its electric-vehicle drivers across the United States and Canada.
A
C
R
U
R

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Oct 7 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1050 GMT on Monday: ** IT firm Atos ATOS.PA is still aiming to reach a deal with the French state on the sale of its most strategic activities such as cybersecurity and super-computing, it said on Monday, after an initial government offer expired.
A
C
R
U

Ubisoft jumps as it says it reviews strategic options after buyout report

BUZZ-Ubisoft jumps as it says it reviews strategic options after buyout report ** Shares in Ubisoft UBIP.PA continue to climb for a second session after it said it was reviewing strategic options following a report on a possible buyout, rising 6% and topping France's SBF 120 index .SBF120 ** It says it "regularly reviews all its strategic options"
U

Borregaard ASA, Evotec SE, PVA TePla AG

EUROPE RESEARCH ROUNDUP-Borregaard ASA, Evotec SE, PVA TePla AG Oct 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Borregaard ASA, Evotec SE and PVA TePla AG, on Monday. HIGHLIGHTS * Borregaard ASA BRGB.OL : Berenberg raises to buy from hold * Evotec SE EVTG.DE : Jefferies cuts to hold from buy * Experian EXPN.L : Deutsche Bank raises to buy from hold * Intertek Group ITRK.L : Deutsche Bank raises to hold from sell * PVA TePla A
D
E
S
U
A
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.